These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Progress in the leukemic stem cell study and a novel therapeutic approach targeting leukemic stem cells]. Kikushige Y; Miyamoto T; Akashi K Rinsho Ketsueki; 2017; 58(10):1838-1843. PubMed ID: 28978822 [TBL] [Abstract][Full Text] [Related]
4. Leukemia Stem Cells Microenvironment. Tabe Y; Konopleva M Adv Exp Med Biol; 2017; 1041():19-32. PubMed ID: 29204827 [TBL] [Abstract][Full Text] [Related]
5. Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities. Marchand T; Pinho S Front Immunol; 2021; 12():775128. PubMed ID: 34721441 [TBL] [Abstract][Full Text] [Related]
6. Eradication of leukemia stem cells as a new goal of therapy in leukemia. Ravandi F; Estrov Z Clin Cancer Res; 2006 Jan; 12(2):340-4. PubMed ID: 16428470 [TBL] [Abstract][Full Text] [Related]
7. Targeted elimination of leukemia stem cells; a new therapeutic approach in hemato-oncology. ten Cate B; de Bruyn M; Wei Y; Bremer E; Helfrich W Curr Drug Targets; 2010 Jan; 11(1):95-110. PubMed ID: 20017722 [TBL] [Abstract][Full Text] [Related]
8. Expression of putative leukemia stem cell targets in genetically-defined acute myeloid leukemia subtypes. Yanagisawa B; Perkins B; Karantanos T; Levis M; Ghiaur G; Smith BD; Jones RJ Leuk Res; 2020 Dec; 99():106477. PubMed ID: 33220589 [TBL] [Abstract][Full Text] [Related]
9. Regulation of hematopoietic and leukemic stem cells by the immune system. Riether C; Schürch CM; Ochsenbein AF Cell Death Differ; 2015 Feb; 22(2):187-98. PubMed ID: 24992931 [TBL] [Abstract][Full Text] [Related]
10. Right on target: eradicating leukemic stem cells. Krause DS; Van Etten RA Trends Mol Med; 2007 Nov; 13(11):470-81. PubMed ID: 17981087 [TBL] [Abstract][Full Text] [Related]
11. Differential destruction of stem cells: implications for targeted cancer stem cell therapy. Sehl ME; Sinsheimer JS; Zhou H; Lange KL Cancer Res; 2009 Dec; 69(24):9481-9. PubMed ID: 19996291 [TBL] [Abstract][Full Text] [Related]
12. CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia. Liu Y; Wang G; Zhang J; Chen X; Xu H; Heng G; Chen J; Zhao Y; Li J; Ni Y; Zhang Y; Shan J; Qian C Stem Cell Res Ther; 2021 Jan; 12(1):86. PubMed ID: 33494824 [TBL] [Abstract][Full Text] [Related]
13. Leukemia stem cells. Testa U Ann Hematol; 2011 Mar; 90(3):245-71. PubMed ID: 21107841 [TBL] [Abstract][Full Text] [Related]
14. Leukemic stem cells: where do they come from? Passegué E; Weisman IL Stem Cell Rev; 2005; 1(3):181-8. PubMed ID: 17142854 [TBL] [Abstract][Full Text] [Related]
15. Kindlin-3 loss curbs chronic myeloid leukemia in mice by mobilizing leukemic stem cells from protective bone marrow niches. Krenn PW; Koschmieder S; Fässler R Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24326-24335. PubMed ID: 32929022 [TBL] [Abstract][Full Text] [Related]
17. Characteristics of leukemic stem cells in acute leukemia and potential targeted therapies for their specific eradication. Hansen Q; Bachas C; Smit L; Cloos J Cancer Drug Resist; 2022; 5(2):344-367. PubMed ID: 35800375 [TBL] [Abstract][Full Text] [Related]
18. Oxidative resistance of leukemic stem cells and oxidative damage to hematopoietic stem cells under pro-oxidative therapy. Chen Y; Liang Y; Luo X; Hu Q Cell Death Dis; 2020 Apr; 11(4):291. PubMed ID: 32341354 [TBL] [Abstract][Full Text] [Related]
19. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia. Lefort S; Maguer-Satta V Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132 [TBL] [Abstract][Full Text] [Related]
20. Survival regulation of leukemia stem cells. Hu Y; Li S Cell Mol Life Sci; 2016 Mar; 73(5):1039-50. PubMed ID: 26686687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]